CORT is trading 4% up at $90.44, extending its strong recent uptrend despite a mixed broader market.
- Recent analysis highlights bullish sentiment and upside potential based on fundamentals and valuation.
- There are no fresh earnings, FDA approvals, M&A activity, or major news items explicitly linked to today’s move.
- The gain appears to be driven by continuation momentum rather than a reaction to a new, specific event.